CATABASIS PHARMACEUTICALS INC

FREE EMAIL WATCHDOG

Get free email notifications about news in CATABASIS PHARMACEUTICALS INC.

The service is free and you can unsubscribe at any time.

General | People (42) | Filings (135) | Investment rounds (8) | Annual reports (2) | Stock | News

Industry: PHARMACEUTICAL PREPARATIONS [2834]

CIK Number: 0001454789

CATABASIS PHARMACEUTICALS INC is a publicly traded company

Trading symbol: CATB

CATABASIS PHARMACEUTICALS INC is on the market more than 5 years.

News

2017-08-17

Cheap Stock Alert & Update on Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB)
FLBC News
Keen investors are consistently searching for true bargains in the stock market. Finding these stocks can make the difference between a winning or losing portfolio.
Chartists Placing Catabasis Pharmaceuticals Inc (CATB) on Their Radar - Stock Daily Review
Catabasis Pharmaceuticals Inc (CATB) Showing Bullish Money Flow - Geneva Journal

2017-08-16

Catabasis Pharmaceuticals (NASDAQ:CATB) Receiving Somewhat Favorable Press ...
BNB Daily (blog)
Oppenheimer Holdings, Inc. decreased their price objective on shares of Catabasis Pharmaceuticals from $9.00 to $4.00 and set an “outperform” rating on the stock in a research report on Tuesday.

2017-08-15

Unusual Activity Spotted in Catabasis Pharmaceuticals Inc (CATB)
Stock Rover
Shares of Catabasis Pharmaceuticals Inc (CATB) is moving on volatility today 1.68% or 0.02 from the open. The NASDAQ listed company saw a recent bid of 1.21 on 54301 volume.

2017-08-14

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) Given Consensus Recommendation ...
BNB Daily (blog)
Catabasis Pharmaceuticals logo Shares of Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) have received an average recommendation of “Buy” from the six ratings firms that are currently covering the company, Marketbeat.
HC Wainwright Increases Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) Price ... - StockNewsTimes
Catabasis Pharmaceuticals (CATB) Investors: Oppenheimer Reaffirms Buy Rating ... - FlintDaily.com

2017-08-11

Catabasis Pharmaceuticals, Inc. (CATB) noted a price change of -2.44% and ...
Stocks Gallery
In recent trading day Catabasis Pharmaceuticals, Inc. (CATB) stock showed the move of -2.44% with the closing price of $1.20.
Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) Announces Quarterly Earnings ... - Sports Perspectives
Catabasis Pharmaceuticals, Inc. (CATB) Issues Earnings Results, Beats ... - Markets Daily

2017-08-10

Catabasis Pharmaceuticals Reports Second Quarter 2017 Financial Results and ...
Business Wire (press release)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today reported financial results for the second quarter ended June 30, 2017, and reviewed recent business progress.
Catabasis Pharmaceuticals' (CATB) CEO Jill Milne on Q2 2017 Results - Earnings ... - Seeking Alpha
Analysts Set Catabasis Pharmaceuticals, Inc. (CATB) PT at $6.25 - Community Financial News

2017-08-09

Needle Action Activity Spotted in Catabasis Pharmaceuticals Inc (CATB)
Stock Daily Review
Shares of Catabasis Pharmaceuticals Inc (CATB) are moving on volatility today 2.36% or 0.03 from the open. The NASDAQ listed company saw a recent bid of 1.30 and 2510 shares have traded hands in the session.

CATABASIS PHARMACEUTICALS INC address

ONE KENDALL SQUARE
BLDG. 1400E, SUITE B14202
CAMBRIDGE
02139

Company jurisdiction

DELAWARE

Entity type

Corporation

Earliest known filing

January 2009

Latest known filing

August 2017

Company filings

SEC filings are a great source of information for companies including investments, company events, and all sorts of other information.

CATABASIS PHARMACEUTICALS INC has 135 filings. View CATABASIS PHARMACEUTICALS INC filings.

Annual Reports

Quarterly Reports

Latest company events

Investment Rounds

CATABASIS PHARMACEUTICALS INC recieved 8 investments.

People

We have found 42 people related to CATABASIS PHARMACEUTICALS INC.